Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:abbreviation |
gptkb:BsUFA
|
| gptkbp:administeredBy |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:appliesTo |
biosimilar biological products
|
| gptkbp:approvedBy |
gptkb:BsUFA_II
gptkb:BsUFA_III gptkb:BsUFA_IV |
| gptkbp:dateEnacted |
2012
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| https://www.w3.org/2000/01/rdf-schema#label |
Biosimilar User Fee Act
|
| gptkbp:partOf |
gptkb:Food_and_Drug_Administration_Safety_and_Innovation_Act
|
| gptkbp:purpose |
to authorize the FDA to collect user fees for biosimilar biological products
|
| gptkbp:relatedTo |
gptkb:Generic_Drug_User_Fee_Amendments
gptkb:Prescription_Drug_User_Fee_Act |
| gptkbp:bfsParent |
gptkb:Food_and_Drug_Administration_Safety_and_Innovation_Act
|
| gptkbp:bfsLayer |
6
|